Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
0.247
-0.003
-1.04%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Asensus Surgical Inc (ASXC)
Add to/Remove from a Portfolio
Add to Watchlist
After Hours
0.250
+0.003
+1.174%
23:09:46 - Real-time Data
- Volume: 810,591
- Bid/Ask: 0.245 / 0.250
- Day's Range: 0.245 - 0.251
Type:
Equity
Market:
United States
Asensus Surgical
0.247
-0.003
-1.04%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
ASXC Income Statement & Profits
Assess the Asensus Surgical Inc income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
Advanced Income Statement 
| Period Ending: | 2023 31/12 |
2023 30/09 |
2023 30/06 |
2023 31/03 |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.43 | 1.09 | 1.08 | 0.976 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Cost of Revenue, Total | 4.26 | 2.87 | 3.07 | 2.95 | ||||||||||||||||||||||||||||||
| Gross Profit | 1.17 | -1.78 | -1.99 | -1.97 | ||||||||||||||||||||||||||||||
| Total Operating Expenses | 20.76 | 20.98 | 21.74 | 23.22 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Operating Income | -15.33 | -19.89 | -20.66 | -22.24 | ||||||||||||||||||||||||||||||
| Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
| Gain (Loss) on Sale of Assets | - | - | - | - | ||||||||||||||||||||||||||||||
| Other, Net | 1.72 | -1.63 | 0.014 | -0.116 | ||||||||||||||||||||||||||||||
| Net Income Before Taxes | -17.06 | -18.26 | -20.67 | -22.13 | ||||||||||||||||||||||||||||||
| Provision for Income Taxes | 0.178 | 0.057 | -0.012 | 0.091 | ||||||||||||||||||||||||||||||
| Net Income After Taxes | -17.24 | -18.32 | -20.66 | -22.22 | ||||||||||||||||||||||||||||||
| Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
| Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
| U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income Before Extraordinary Items | -17.24 | -18.32 | -20.66 | -22.22 | ||||||||||||||||||||||||||||||
| Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income | -17.24 | -18.32 | -20.66 | -22.22 | ||||||||||||||||||||||||||||||
| Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
| Income Available to Common Excluding Extraordinary Items | -17.24 | -18.32 | -20.66 | -22.22 | ||||||||||||||||||||||||||||||
| Dilution Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Net Income | -17.24 | -18.32 | -20.66 | -22.22 | ||||||||||||||||||||||||||||||
| Diluted Weighted Average Shares | 264.35 | 256.18 | 239.57 | 238.28 | ||||||||||||||||||||||||||||||
| Diluted EPS Excluding Extraordinary Items | -0.065 | -0.072 | -0.086 | -0.093 | ||||||||||||||||||||||||||||||
| DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Normalized EPS | -0.039 | -0.044 | -0.053 | -0.058 | ||||||||||||||||||||||||||||||
* In Millions of USD (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Asensus Surgical Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Victor Oltean
Feb 04, 2022 22:28
https://ir.asensus.com/sec-filings/sec-filing/sc-13g/0000834237-22-007190
0
0
Victor Oltean
Feb 04, 2022 22:28
https://ir.asensus.com/sec-filings/sec-filing/sc-13g/0000834237-22-007190
0
0
Chris Guy
Apr 15, 2021 18:03
what dog this has turned out to be
1
0
William Streitberg
Apr 13, 2021 5:30
This is a strong hold, im buying more
0
0
Marios Tegopoulos
Mar 03, 2021 17:06
hold & buy!
4
0
Riccardo Gubbiotti
Mar 03, 2021 12:21
Hold this beauty!
3
0
Anfangell Anfangell
Feb 08, 2021 20:06
Hold the diamond ;))))
9
0
melissa raking
Jan 31, 2021 9:37
TRXC is an uncut diamond. It doesn't get much love by many compare to ISRG who monopolise the market but it surgical robots tecnology sure have an equal value if not more than ISRG.
4
0
melissa raking
Jan 31, 2021 9:37
Its CEO is a guy from Stryker. The eye sensor is amazing, the leasing idea is brilliant & data collecting sounds like moving forward Ai robots in future. Remember 5G is coming. I bought Virgin Galatic stock as soon as I opened my account after almost a decade been away from stock trading now it is at the runway ready to fly. I'm a futurist trader-investor. This is the stock that I will buy & hold (for those who haven't). You can buy now for at least a thousand unit or buy years later with only tens unit, your choice. TRXC robot is my Atom (Real Steel) & ISRG robot is Zeus. This is the battle between 2 bots and I always with the underdog.
3
0
Milan Rajani
Jan 21, 2021 15:56
I have positve vibes on this
4
0
Charlie palmer
Jan 21, 2021 12:58
if the price goes anywhere remotely near the price of 2018 or even 2019 we will be laughing but I highly doubt it will reach that high again 🤔🤔
4
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review